Haleon (LON:HLN) Stock Price Up 0.3% – What’s Next?

Haleon plc (LON:HLN)’s stock price was up 0.3% on Thursday . The stock traded as high as GBX 391.80 ($4.92) and last traded at GBX 391.69 ($4.92). Approximately 10,667,455 shares changed hands during mid-day trading, a decline of 61% from the average daily volume of 27,116,525 shares. The stock had previously closed at GBX 390.50 ($4.91).

Haleon Stock Up 0.3 %

The company has a market cap of £35.35 billion, a price-to-earnings ratio of 32.94, a P/E/G ratio of 1.49 and a beta of 0.19. The stock’s 50-day moving average is GBX 377.36 and its 200-day moving average is GBX 376.91. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36.

Insider Buying and Selling at Haleon

In other Haleon news, insider Dawn Allen sold 74,679 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.68), for a total value of £277,805.88 ($349,133.94). Insiders own 10.74% of the company’s stock.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.